These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 18362365)

  • 41. Impact of F-18 fluorodeoxyglucose positron emission tomography-computed tomography on oncologic patient management: first 2 years' experience at a single Canadian cancer center.
    Worsley DF; Wilson DC; Powe JE; Benard F
    Can Assoc Radiol J; 2010 Feb; 61(1):13-8. PubMed ID: 19819103
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.
    Pfau PR; Perlman SB; Stanko P; Frick TJ; Gopal DV; Said A; Zhang Z; Weigel T
    Gastrointest Endosc; 2007 Mar; 65(3):377-84. PubMed ID: 17321235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Utility of PET/neck MRI digital fusion images in the management of recurrent or persistent thyroid cancer.
    Seiboth L; Van Nostrand D; Wartofsky L; Ousman Y; Jonklaas J; Butler C; Atkins F; Burman K
    Thyroid; 2008 Feb; 18(2):103-11. PubMed ID: 18279011
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
    Basu D; Siegel BA; McDonald DJ; Nussenbaum B
    Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PET/CT may change diagnosis and treatment in cancer patients.
    Petersen H; Nielsen MJ; Høilund-Carlsen M; Gerke O; Vach W; Høilund-Carlsen PF
    Dan Med Bull; 2010 Sep; 57(9):A4178. PubMed ID: 20816018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PET/CT: will it change the way that we use CT in cancer imaging?
    Hicks RJ; Ware RE; Lau EW
    Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of PET/CT on management of patients with esophageal cancer - results from a PET/CT registry study.
    Reinert CP; Sekler J; Gani C; Nikolaou K; la Fougère C; Pfannenberg C; Gatidis S
    Eur J Radiol; 2021 Mar; 136():109524. PubMed ID: 33434862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Positron emission tomography/computed tomography introduction in the clinical management of patients with suspected recurrence of ovarian cancer: a cost-effectiveness analysis.
    Mansueto M; Grimaldi A; Mangili G; Picchio M; Giovacchini G; Viganò R; Messa C; Fazio F
    Eur J Cancer Care (Engl); 2009 Nov; 18(6):612-9. PubMed ID: 19549284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management.
    Keidar Z; Haim N; Guralnik L; Wollner M; Bar-Shalom R; Ben-Nun A; Israel O
    J Nucl Med; 2004 Oct; 45(10):1640-6. PubMed ID: 15471827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concordance of positron emission tomography and computed tomography in patients with locally advanced gastric and esophageal cancer.
    Hocazade C; Özdemir N; Yazici O; Bozkaya Y; Yazılıtaş D; Toptaş Ş; Zengin N; Deren T
    Ann Nucl Med; 2015 Aug; 29(7):621-6. PubMed ID: 26008856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does positron emission tomography change management in primary rectal cancer? A prospective assessment.
    Heriot AG; Hicks RJ; Drummond EG; Keck J; Mackay J; Chen F; Kalff V
    Dis Colon Rectum; 2004 Apr; 47(4):451-8. PubMed ID: 14978612
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
    Tuncel M; Souvatzoglou M; Herrmann K; Stollfuss J; Schuster T; Weirich G; Wester HJ; Schwaiger M; Krause BJ
    Nucl Med Biol; 2008 Aug; 35(6):689-95. PubMed ID: 18678354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PET and PET/CT reports: observations from the National Oncologic PET Registry.
    Coleman RE; Hillner BE; Shields AF; Duan F; Merlino DA; Hanna LG; Stine SH; Siegel BA
    J Nucl Med; 2010 Jan; 51(1):158-63. PubMed ID: 20008997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variation in positron emission tomography use after colon cancer resection.
    Bailey CE; Hu CY; You YN; Kaur H; Ernst RD; Chang GJ
    J Oncol Pract; 2015 May; 11(3):e363-72. PubMed ID: 25852143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Positron Emission Tomography/Computed Tomography for Gynecologic Malignancies.
    Oldan JD; Patel PS
    Obstet Gynecol Surv; 2016 Sep; 71(9):545-56. PubMed ID: 27640609
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of PET scanning on management of paediatric oncology patients.
    Wegner EA; Barrington SF; Kingston JE; Robinson RO; Ferner RE; Taj M; Smith MA; O'Doherty MJ
    Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):23-30. PubMed ID: 15290124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth in the use of PET for six cancer types after coverage by medicare: additive or replacement?
    Hillner BE; Tosteson AN; Song Y; Tosteson TD; Onega T; Goodman DC; Siegel BA
    J Am Coll Radiol; 2012 Jan; 9(1):33-41. PubMed ID: 22221634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches.
    Buck AK; Herrmann K; Stargardt T; Dechow T; Krause BJ; Schreyögg J
    J Nucl Med Technol; 2010 Mar; 38(1):6-17. PubMed ID: 20197541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative effectiveness of follow-up imaging approaches in pancreatic cancer.
    Reeder-Hayes KE; Freburger J; Feaganes J; Peacock Hinton S; Henderson LM; Massing M; Schenck AP; Stearns SC; Carpenter WR; Chen RC; Khandani AH
    J Comp Eff Res; 2014 Sep; 3(5):491-502. PubMed ID: 25350801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.